您当前的位置:首页 > 核医学

经皮穿刺锁骨下动脉腔内成形术

时间:2005-09-06 17:14:40  来源:  作者:

Percutaneous transluminal angioplasty of the subclavian artery

张青 金征宇 杨宇 刘巍 
潘杰 黄一宁 高山 戴建平

<?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" /> 

ABSTRACT

ObjectiveTo evaluate the effect and safety of percutaneous transluminal angioplasty(PTA) of subclavian artery. Methods :76 patients with severe stenosis or total occlusion of subclavian artery were treated with PTA. Symptoms of vertebrobasilar and (or) upper extremity arterial insufficiency were present in all patients. Digital subtraction angiography (DSA) showed that 69 had severe stenosis and 7 had total occlusion of the subclavian artery before PTA. 68 lesions were successfully dilate and stents were implanted in other 8 lesions. Results: The symptoms disappeared or alleviates obviously in all patients after PTA. DSA and transcranial Doppler ultrasonography (TCD) confimed that subclavian steal was corrected in 45 patients. There were only 3 minor-complications (2 pescudoaneurysms at puncture site, 1 transient dizziness during PTA) .During the follow-up of 4 to 35 months (average 29 months) , there were only three re-stenosis.
Conclusion: PTA is an effective and safe method to treat severe stenosis or total occlusion of subclavian artery. The rate of complications was lower than that of operative treatment.
  
Key words: Angioplasty; Subclavian artery; Arterial occlusive disease 
Qing Zhang, Zhengyu Jin,Yu Yang, et al. Department of radiology, Beijing Union Hospital, Chinese Academy of Medical Sciences, Beijing Union Medical College, Beijing 100730, China

  自1964年Dotter等[1]首次报道经皮腔内血管成形术(PTA)以来,随着球囊扩张导管的不断改进,PTA已被广泛应用于治疗动脉粥样硬化疾病。1980年Kerber等[2]首次成功地扩张了颈内动脉狭窄,但因可能发生脑动脉栓塞,PTA对于治疗主动脉弓上区域血管(锁骨下动脉、颈动脉)的疗效任存在争议。笔者对76例锁骨下动脉狭窄或闭塞患者进行了锁骨下动脉成形术,取得了满意效果。

材料与方法

1、 临床资料:自1994年2月至2000年8月对76例锁骨下动脉病变的患者行PTA治疗。锁骨下动脉狭窄69例(90.8%),其中左侧狭窄45例,右侧狭窄24例;完全闭塞7例(9.2%),其中左侧闭塞6例,右侧闭塞1例。患者年龄45-72岁,平均58.7岁,男61例,女15例。行单纯球囊扩张术68例,放置支架8例。

 

来顶一下
返回首页
返回首页
 
推荐资讯
掌间筑未来,西门子医疗推出全新CT产品SOMATOM go.
掌间筑未来,西门子医疗
“智”动创新 共享“健康中国” 西门子医疗亮相2017 HOSPEQ
“智”动创新 共享“
西门子医疗携一系列创新成果亮相CMEF 2017   助力“智慧”医疗服务建设
西门子医疗携一系列创
西门子医疗中国亮相第77届中国国际医疗器械春季博览会,多方位展示互联网时代下 “智慧”成果
西门子医疗中国亮相第
最后更新
热门点击
  1. 21世纪核医学需要什么样的技术人员?
  2. 渗透压对对比剂肾病发生率的影响:有关在高
  3. 核医学技师出路在何方?对核医学技术人员队伍
  4. PET-CT在肾上腺肿瘤诊断中的诊断效能和判读
  5. 核医学:传统经典的新兴学科
  6. 冠状动脉造影、心电图、核素检查对冠心病诊
  7. 核医学检查对人体有伤害吗?
  8. 《走进核医学》教学录相片的制作
  9. 高分辨率 MRI 可确诊大脑前动脉夹层
  10. 内皮抑素基因联合放射治疗对大鼠Walker-256